Metabolic dysfunction-associated steatotic liver disease (MASLD) is a complex multifactorial
disease and becoming the leading cause of liver-related morbidity and mortality. MASLD …

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a growing global health
problem, affecting∼ 1 billion people. This condition is well established to have a heritable …

Steatotic liver disease (SLD) prevails as the most common chronic liver disease yet lack
approved treatments due to incomplete understanding of pathogenesis. Recently, elevated …

Over the past 10 years, the biological role of lipid droplets (LDs) has gained significant
attention in the context of both physiological and pathological conditions. Considerable …

Non-alcoholic fatty liver disease (NAFLD) is a common and prevalent disorder affecting 25
percent of the adults in the United States and 32 percent of adults globally. It is one of the …

Steatotic liver disease (SLD) refers to a spectrum of diseases caused by hepatic lipid
accumulation. SLD has emerged as the leading cause of chronic liver disease worldwide …

Much more than a histological feature, lipid droplets are complex heterogenous organelles
crucial to cellular metabolism with important causative roles in the development and …

The literature review highlights the issue of genetic risk factors associated with the
development of metabolic dysfunction-associated fatty liver disease. Human genetic …

TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant
decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD” …

Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) is the most prevalent
chronic liver disease and the major cause of liver-related mortality worldwide 1. MASLD is …